Anamorelin HCl, a ghrelin analogue with an extended half‐life, has undergone extensive testing in phase I, II, and III trials, demonstrating good tolerability and effectiveness in improving weight gain, lean muscle mass, and anorexic/cachectic symptoms in cachectic cancer patients.887, 888, 889, 890. This evidence concerns the gene GHRL and cancer.